Works by Lan, Yuan-Tzu

Results: 53
    1

    Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer.

    Published in:
    International Journal of Colorectal Disease, 2024, v. 39, n. 1, p. 1, doi. 10.1007/s00384-024-04767-9
    By:
    • Tseng, Kuan-Yu;
    • Yang, Mu-Ying;
    • Chen, Wei-Shone;
    • Jiang, Jeng-Kai;
    • Wang, Huann-Sheng;
    • Chang, Shih-Ching;
    • Lan, Yuan-Tzu;
    • Lin, Chun-Chi;
    • Lin, Hung-Hsin;
    • Huang, Sheng-Chieh;
    • Cheng, Hou-Hsuan;
    • Yang, Yi-Wen;
    • Lin, Yu-Zu;
    • Chang, Che-Yuan;
    • Teng, Hao-Wei
    Publication type:
    Article
    2

    Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 12, p. 1534, doi. 10.1634/theoncologist.2019-0171
    By:
    • Chen, Ming‐Huang;
    • Chang, Shih‐Ching;
    • Lin, Pei‐Ching;
    • Yang, Shung‐Haur;
    • Lin, Chun‐Chi;
    • Lan, Yuan‐Tzu;
    • Lin, Hung‐Hsin;
    • Lin, Chien‐Hsing;
    • Lai, Jiun‐I;
    • Liang, Wen‐Yi;
    • Lu, Meng‐Lun;
    • Yang, Muh‐Hwa;
    • Chao, Yee
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Advances in Laparoscopic and Robotic Gastrectomy for Gastric Cancer.

    Published in:
    Pathology & Oncology Research, 2017, v. 23, n. 1, p. 13, doi. 10.1007/s12253-016-0131-0
    By:
    • Tsai, Sheng-Han;
    • Liu, Chien-An;
    • Huang, Kuo-Hung;
    • Lan, Yuan-Tzu;
    • Chen, Ming-Huang;
    • Chao, Yee;
    • Lo, Su-Shun;
    • Li, Anna;
    • Wu, Chew-Wun;
    • Chiou, Shih-Hwa;
    • Yang, Muh-Hwa;
    • Shyr, Yi-Ming;
    • Fang, Wen-Liang
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.

    Published in:
    Journal of Surgical Oncology, 2012, v. 106, n. 2, p. 123, doi. 10.1002/jso.23063
    By:
    • Teng, Hao-Wei;
    • Huang, Yu-Chung;
    • Lin, Jen-Kou;
    • Chen, Wei-Shone;
    • Lin, Tzu-Chen;
    • Jiang, Jeng-Kai;
    • Yen, Chueh-Chuan;
    • Li, Anna Fen-Yau;
    • Wang, Hsei-Wei;
    • Chang, Shih-Ching;
    • Lan, Yuan-Tzu;
    • Lin, Chun-Chi;
    • Wang, Huann-Sheng;
    • Yang, Shung-Haur
    Publication type:
    Article
    25
    26

    Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response-a retrospective study

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 11, p. 1927, doi. 10.1007/s00432-014-1741-0
    By:
    • Yang, Yuan-Hao;
    • Lin, Jen-Kou;
    • Chen, Wei-Shone;
    • Lin, Tzu-Chen;
    • Yang, Shung-Haur;
    • Jiang, Jeng-Kai;
    • Lan, Yuan-Tzu;
    • Lin, Chun-Chi;
    • Yen, Chueh-Chuan;
    • Tzeng, Cheng-Hwai;
    • Teng, Hao-Wei
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    The role of adjuvant chemotherapy in stage II colorectal cancer patients.

    Published in:
    International Journal of Colorectal Disease, 2014, v. 29, n. 10, p. 1237, doi. 10.1007/s00384-014-1943-6
    By:
    • Lin, Hung-Hsin;
    • Chang, Yu-Yao;
    • Lin, Jen-Kou;
    • Jiang, Jeng-Kai;
    • Lin, Chun-Chi;
    • Lan, Yuan-Tzu;
    • Yang, Shung-Haur;
    • Wang, Huann-Sheng;
    • Chen, Wei-Shone;
    • Lin, Tzu-Chen;
    • Chang, Shih-Ching
    Publication type:
    Article
    33
    34
    35
    36

    Clinicopathologic features and prognostic analysis of MSI-high colon cancer.

    Published in:
    International Journal of Colorectal Disease, 2012, v. 27, n. 3, p. 277, doi. 10.1007/s00384-011-1341-2
    By:
    • Lin, Chun-Chi;
    • Lai, Yi-Ling;
    • Lin, Tzu-Chen;
    • Chen, Wei-Shone;
    • Jiang, Jeng-Kai;
    • Yang, Shung-Haur;
    • Wang, Huann-Sheng;
    • Lan, Yuan-Tzu;
    • Liang, Wen-Yih;
    • Hsu, Hui-Mei;
    • Lin, Jen-Kou;
    • Chang, Shih-Ching
    Publication type:
    Article
    37
    38

    Clinical significance of circulating plasma DNA in gastric cancer.

    Published in:
    International Journal of Cancer, 2016, v. 138, n. 12, p. 2974, doi. 10.1002/ijc.30018
    By:
    • Fang, Wen‐Liang;
    • Lan, Yuan‐Tzu;
    • Huang, Kuo‐Hung;
    • Liu, Chien‐An;
    • Hung, Yi‐Ping;
    • Lin, Chien‐Hsing;
    • Jhang, Fang‐Yu;
    • Chang, Shih‐Ching;
    • Chen, Ming‐Huang;
    • Chao, Yee;
    • Lin, Wen‐Chang;
    • Lo, Su‐Shun;
    • Fen‐Yau Li, Anna;
    • Wu, Chew‐Wun;
    • Chiou, Shih‐Hwa;
    • Shyr, Yi‐Ming
    Publication type:
    Article
    39

    Pneumothorax After Bevacizumab-containing Chemotherapy: A Case Report.

    Published in:
    Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 269, doi. 10.1093/jjco/hyq195
    By:
    • Yang, Sheng-Hsiang;
    • Lin, Jen-Kou;
    • Chen, Wei-Shone;
    • Lin, Tzu-Chen;
    • Yang, Shung-Haur;
    • Jiang, Jeng-Kai;
    • Chang, Shih-Ching;
    • Lan, Yuan-Tzu;
    • Chao, Ta-Chung;
    • Yen, Chueh-Chuan;
    • Tzeng, Cheng-Hwai;
    • Teng, Hao-Wei
    Publication type:
    Article
    40
    41
    42

    Clinical outcome of local treatment and radical resection for pT1 rectal cancer.

    Published in:
    International Journal of Colorectal Disease, 2022, v. 37, n. 8, p. 1845, doi. 10.1007/s00384-022-04220-9
    By:
    • Pai, Summer Sheue-Tsuey;
    • Lin, Hung-Hsin;
    • Cheng, Hou-Hsuan;
    • Huang, Sheng-Chieh;
    • Lin, Chun-Chi;
    • Lan, Yuan-Tzu;
    • Wang, Huann-Sheng;
    • Yang, Shung-Haur;
    • Jiang, Jeng-Kai;
    • Chen, Wei-Shone;
    • Lin, Jen-Kou;
    • Chang, Shih-Ching
    Publication type:
    Article
    43
    44
    45

    Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 7, p. 2262, doi. 10.1245/s10434-014-4228-y
    By:
    • Huang, Sheng-Chieh;
    • Lin, Jen-Kou;
    • Lin, Tzu-Chen;
    • Chen, Wei-Shone;
    • Yang, Shung-Haur;
    • Wang, Huann-Sheng;
    • Lan, Yuan-Tzu;
    • Lin, Chun-Chi;
    • Jiang, Jeng-Kai;
    • Chang, Shih-Ching
    Publication type:
    Article
    46
    47
    48
    49
    50

    Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94968-x
    By:
    • Hsu, Hung-Chih;
    • Huang, Kuo-Cheng;
    • Chen, Wei-Shone;
    • Jiang, Jeng-Kai;
    • Yang, Shung-Haur;
    • Wang, Huann-Sheng;
    • Chang, Shih-Ching;
    • Lan, Yuan-Tzu;
    • Lin, Chun-Chi;
    • Lin, Hung-Hsin;
    • Huang, Sheng-Chieh;
    • Cheng, Hou-Hsuan;
    • Yang, Tsai-Sheng;
    • Chen, Chien-Chih;
    • Chao, Yee;
    • Teng, Hao-Wei
    Publication type:
    Article